Making medicines
more manageable
Who we are and what we do
At Colonis, we make medicines more manageable for patients. By identifying and understanding how unmet clinical needs impact patients, we develop established molecules into treatment options that healthcare professionals can use to improve the lives and outcomes of patients.
What truly sets us apart is our ability to identify unique opportunities to repurpose and reformulate established medicines for unmet clinical needs, develop these formulations through a rigorous process, and commercialise them across Europe to give access to patients and healthcare professionals.
Our mission is to support patients in receiving the most appropriate and accessible treatment by improving ease of administration and adherence, giving patients a choice to continue their treatment.
Partner with us
We are always on the lookout for pharmaceutical partners. Whether you are a pharmaceutical company seeking to out-license our products for your market or looking to expand the reach of your product portfolio to the UK or further European markets by in-licensing, we can help.
Value-added medicines
At Colonis, we support the unmet clinical needs of patient groups by bringing products to market that patients and healthcare professionals truly need. These value-added medicines offer treatment options to those not having their needs met with current therapies.
Here, you can explore our view of the benefits and the future of value-added medicines.
Our expert analysis of the current marketplace enables us to identify the true necessity and demand for a product and develop patent-expired molecules into products that fulfil an unmet clinical need and extend their lifecycle. Discover more about our product portfolio across a range of therapeutic areas.
Our products
Get in touch
If you’re interested in discussing partnership opportunities or want to learn more about us, we’d love to hear from you.
Connect With Us
